Global Paclitaxel Sales 麻豆原创 Report 2023

Publication ID:

PB501234252

Publication Date:

January 3, 2023

Pages:

126

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,000.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
麻豆原创 Analysis and Insights: Global Paclitaxel 麻豆原创
Due to the COVID-19 pandemic, the global Paclitaxel market size is estimated to be worth US$ 117.6 million in 2022 and is forecast to a readjusted size of US$ 205.5 million by 2029 with a CAGR of 8.2% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Natural Paclitaxel API accounting for % of the Paclitaxel global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Ovarian Cancer segment is altered to an % CAGR throughout this forecast period.
North America and China are the largest producer of Paclitaxel, with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.
Global Paclitaxel Scope and 麻豆原创 Size
The global Paclitaxel market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Paclitaxel market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Segment by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Paclitaxel 麻豆原创 Overview
1.1 Paclitaxel Product Scope
1.2 Paclitaxel Segment by Type
1.2.1 Global Paclitaxel Sales by Type (2018 & 2022 & 2029)
1.2.2 Natural Paclitaxel API
1.2.3 Semi-synthetic Paclitaxel API
1.3 Paclitaxel Segment by Application
1.3.1 Global Paclitaxel Sales Comparison by Application (2018 & 2022 & 2029)
1.3.2 Ovarian Cancer
1.3.3 Cervical Cancer
1.3.4 Breast Cancer
1.3.5 Others
1.4 Paclitaxel 麻豆原创 Estimates and Forecasts (2018-2029)
1.4.1 Global Paclitaxel 麻豆原创 Size in Value Growth Rate (2018-2029)
1.4.2 Global Paclitaxel 麻豆原创 Size in Volume Growth Rate (2018-2029)
1.4.3 Global Paclitaxel Price Trends (2018-2029)
2 Paclitaxel Estimates and Forecasts by Region
2.1 Global Paclitaxel 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2 Global Paclitaxel Retrospective 麻豆原创 Scenario by Region (2018-2023)
2.2.1 Global Paclitaxel Sales 麻豆原创 Share by Region (2018-2023)
2.2.2 Global Paclitaxel Revenue 麻豆原创 Share by Region (2018-2023)
2.3 Global Paclitaxel 麻豆原创 Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Paclitaxel Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Paclitaxel Revenue Forecast by Region (2024-2029)
2.4 Geographic 麻豆原创 Analysis: 麻豆原创 Facts & Figures
2.4.1 United States Paclitaxel Estimates and Projections (2018-2029)
2.4.2 Europe Paclitaxel Estimates and Projections (2018-2029)
2.4.3 China Paclitaxel Estimates and Projections (2018-2029)
2.4.4 Japan Paclitaxel Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Paclitaxel Estimates and Projections (2018-2029)
2.4.6 India Paclitaxel Estimates and Projections (2018-2029)
3 Global Paclitaxel Competition Landscape by Players
3.1 Global Top Paclitaxel Players by Sales (2018-2023)
3.2 Global Top Paclitaxel Players by Revenue (2018-2023)
3.3 Global Paclitaxel 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Paclitaxel as of 2022)
3.4 Global Paclitaxel Average Price by Company (2018-2023)
3.5 Manufacturers Paclitaxel Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Paclitaxel 麻豆原创 Size by Type
4.1 Global Paclitaxel Historic 麻豆原创 Review by Type (2018-2023)
4.1.1 Global Paclitaxel Sales by Type (2018-2023)
4.1.2 Global Paclitaxel Revenue by Type (2018-2023)
4.1.3 Global Paclitaxel Price by Type (2018-2023)
4.2 Global Paclitaxel 麻豆原创 Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Paclitaxel Sales Forecast by Type (2024-2029)
4.2.2 Global Paclitaxel Revenue Forecast by Type (2024-2029)
4.2.3 Global Paclitaxel Price Forecast by Type (2024-2029)
5 Global Paclitaxel 麻豆原创 Size by Application
5.1 Global Paclitaxel Historic 麻豆原创 Review by Application (2018-2023)
5.1.1 Global Paclitaxel Sales by Application (2018-2023)
5.1.2 Global Paclitaxel Revenue by Application (2018-2023)
5.1.3 Global Paclitaxel Price by Application (2018-2023)
5.2 Global Paclitaxel 麻豆原创 Estimates and Forecasts by Application (2024-2029)
5.2.1 Global Paclitaxel Sales Forecast by Application (2024-2029)
5.2.2 Global Paclitaxel Revenue Forecast by Application (2024-2029)
5.2.3 Global Paclitaxel Price Forecast by Application (2024-2029)
6 United States Paclitaxel 麻豆原创 Facts & Figures
6.1 United States Paclitaxel Sales by Company
6.1.1 United States Paclitaxel Sales by Company (2018-2023)
6.1.2 United States Paclitaxel Revenue by Company (2018-2023)
6.2 United States Paclitaxel Sales Breakdown by Type
6.2.1 United States Paclitaxel Sales Breakdown by Type (2018-2023)
6.2.2 United States Paclitaxel Sales Breakdown by Type (2024-2029)
6.3 United States Paclitaxel Sales Breakdown by Application
6.3.1 United States Paclitaxel Sales Breakdown by Application (2018-2023)
6.3.2 United States Paclitaxel Sales Breakdown by Application (2024-2029)
7 Europe Paclitaxel 麻豆原创 Facts & Figures
7.1 Europe Paclitaxel Sales by Company
7.1.1 Europe Paclitaxel Sales by Company (2018-2023)
7.1.2 Europe Paclitaxel Revenue by Company (2018-2023)
7.2 Europe Paclitaxel Sales Breakdown by Type
7.2.1 Europe Paclitaxel Sales Breakdown by Type (2018-2023)
7.2.2 Europe Paclitaxel Sales Breakdown by Type (2024-2029)
7.3 Europe Paclitaxel Sales Breakdown by Application
7.3.1 Europe Paclitaxel Sales Breakdown by Application (2018-2023)
7.3.2 Europe Paclitaxel Sales Breakdown by Application (2024-2029)
8 China Paclitaxel 麻豆原创 Facts & Figures
8.1 China Paclitaxel Sales by Company
8.1.1 China Paclitaxel Sales by Company (2018-2023)
8.1.2 China Paclitaxel Revenue by Company (2018-2023)
8.2 China Paclitaxel Sales Breakdown by Type
8.2.1 China Paclitaxel Sales Breakdown by Type (2018-2023)
8.2.2 China Paclitaxel Sales Breakdown by Type (2024-2029)
8.3 China Paclitaxel Sales Breakdown by Application
8.3.1 China Paclitaxel Sales Breakdown by Application (2018-2023)
8.3.2 China Paclitaxel Sales Breakdown by Application (2024-2029)
9 Japan Paclitaxel 麻豆原创 Facts & Figures
9.1 Japan Paclitaxel Sales by Company
9.1.1 Japan Paclitaxel Sales by Company (2018-2023)
9.1.2 Japan Paclitaxel Revenue by Company (2018-2023)
9.2 Japan Paclitaxel Sales Breakdown by Type
9.2.1 Japan Paclitaxel Sales Breakdown by Type (2018-2023)
9.2.2 Japan Paclitaxel Sales Breakdown by Type (2024-2029)
9.3 Japan Paclitaxel Sales Breakdown by Application
9.3.1 Japan Paclitaxel Sales Breakdown by Application (2018-2023)
9.3.2 Japan Paclitaxel Sales Breakdown by Application (2024-2029)
10 Southeast Asia Paclitaxel 麻豆原创 Facts & Figures
10.1 Southeast Asia Paclitaxel Sales by Company
10.1.1 Southeast Asia Paclitaxel Sales by Company (2018-2023)
10.1.2 Southeast Asia Paclitaxel Revenue by Company (2018-2023)
10.2 Southeast Asia Paclitaxel Sales Breakdown by Type
10.2.1 Southeast Asia Paclitaxel Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Paclitaxel Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Paclitaxel Sales Breakdown by Application
10.3.1 Southeast Asia Paclitaxel Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Paclitaxel Sales Breakdown by Application (2024-2029)
11 India Paclitaxel 麻豆原创 Facts & Figures
11.1 India Paclitaxel Sales by Company
11.1.1 India Paclitaxel Sales by Company (2018-2023)
11.1.2 India Paclitaxel Revenue by Company (2018-2023)
11.2 India Paclitaxel Sales Breakdown by Type
11.2.1 India Paclitaxel Sales Breakdown by Type (2018-2023)
11.2.2 India Paclitaxel Sales Breakdown by Type (2024-2029)
11.3 India Paclitaxel Sales Breakdown by Application
11.3.1 India Paclitaxel Sales Breakdown by Application (2018-2023)
11.3.2 India Paclitaxel Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Paclitaxel Business
12.1 Phyton
12.1.1 Phyton Corporation Information
12.1.2 Phyton Business Overview
12.1.3 Phyton Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Phyton Paclitaxel Products Offered
12.1.5 Phyton Recent Development
12.2 ScinoPharm
12.2.1 ScinoPharm Corporation Information
12.2.2 ScinoPharm Business Overview
12.2.3 ScinoPharm Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
12.2.4 ScinoPharm Paclitaxel Products Offered
12.2.5 ScinoPharm Recent Development
12.3 Novasep
12.3.1 Novasep Corporation Information
12.3.2 Novasep Business Overview
12.3.3 Novasep Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Novasep Paclitaxel Products Offered
12.3.5 Novasep Recent Development
12.4 Samyang
12.4.1 Samyang Corporation Information
12.4.2 Samyang Business Overview
12.4.3 Samyang Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Samyang Paclitaxel Products Offered
12.4.5 Samyang Recent Development
12.5 Polymed
12.5.1 Polymed Corporation Information
12.5.2 Polymed Business Overview
12.5.3 Polymed Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Polymed Paclitaxel Products Offered
12.5.5 Polymed Recent Development
12.6 TAPI (Teva)
12.6.1 TAPI (Teva) Corporation Information
12.6.2 TAPI (Teva) Business Overview
12.6.3 TAPI (Teva) Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
12.6.4 TAPI (Teva) Paclitaxel Products Offered
12.6.5 TAPI (Teva) Recent Development
12.7 Fresenius-kabi
12.7.1 Fresenius-kabi Corporation Information
12.7.2 Fresenius-kabi Business Overview
12.7.3 Fresenius-kabi Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Fresenius-kabi Paclitaxel Products Offered
12.7.5 Fresenius-kabi Recent Development
12.8 Huiang biopharma
12.8.1 Huiang biopharma Corporation Information
12.8.2 Huiang biopharma Business Overview
12.8.3 Huiang biopharma Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
12.8.4 Huiang biopharma Paclitaxel Products Offered
12.8.5 Huiang biopharma Recent Development
12.9 Southpharma
12.9.1 Southpharma Corporation Information
12.9.2 Southpharma Business Overview
12.9.3 Southpharma Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
12.9.4 Southpharma Paclitaxel Products Offered
12.9.5 Southpharma Recent Development
12.10 Yunnan Hande
12.10.1 Yunnan Hande Corporation Information
12.10.2 Yunnan Hande Business Overview
12.10.3 Yunnan Hande Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
12.10.4 Yunnan Hande Paclitaxel Products Offered
12.10.5 Yunnan Hande Recent Development
12.11 Hainan Yew Pharm
12.11.1 Hainan Yew Pharm Corporation Information
12.11.2 Hainan Yew Pharm Business Overview
12.11.3 Hainan Yew Pharm Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
12.11.4 Hainan Yew Pharm Paclitaxel Products Offered
12.11.5 Hainan Yew Pharm Recent Development
12.12 Jiangsu Yew Biotechnology
12.12.1 Jiangsu Yew Biotechnology Corporation Information
12.12.2 Jiangsu Yew Biotechnology Business Overview
12.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
12.12.4 Jiangsu Yew Biotechnology Paclitaxel Products Offered
12.12.5 Jiangsu Yew Biotechnology Recent Development
13 Paclitaxel Manufacturing Cost Analysis
13.1 Paclitaxel Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Paclitaxel
13.4 Paclitaxel Industrial Chain Analysis
14 麻豆原创ing Channel, Distributors and Customers
14.1 麻豆原创ing Channel
14.2 Paclitaxel Distributors List
14.3 Paclitaxel Customers
15 麻豆原创 Dynamics
15.1 Paclitaxel Industry Trends
15.2 Paclitaxel 麻豆原创 Drivers
15.3 Paclitaxel 麻豆原创 Challenges
15.4 Paclitaxel 麻豆原创 Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

Companies Mentioned:

Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.